75914-67-9

Usage

Explanation

1-cyclobutylurea is a chemical compound composed of 5 carbon atoms, 10 hydrogen atoms, 2 nitrogen atoms, and 1 oxygen atom.

Explanation

The compound consists of a cyclobutyl group (a four-carbon ring structure) attached to a urea functional group (a group containing two amide moieties).

Explanation

1-cyclobutylurea is used as a starting material for creating more complex molecules in the synthesis of organic compounds and pharmaceuticals.

Explanation

Due to its unique structural properties, 1-cyclobutylurea has the potential to be used in the creation of novel drugs and materials.

Explanation

Scientists are actively researching 1-cyclobutylurea to better understand its potential applications and properties in various fields.

Structure

Cyclic urea derivative

Usage

Building block in organic synthesis and pharmaceutical research

Potential applications

Development of new drugs and materials

Ongoing research

Exploration of potential uses and properties

Upstream product

• 2516-34-9 cyclobutylamine 
• 1118-02-1 trimethylsilyl isocyanate 

Relevant academic research and scientific papers

Myosin inhibitor, as well as preparation method and application thereof

The invention relates to the field of medicinal chemistry, in particular to a myosin inhibitor, as well as a preparation method and application thereof. The invention provides a compound or pharmacologically acceptable salt, an isomer, a prodrug, a polymorphic substance or a solvate thereof. A chemical structural formula of the compound is as shown in a formula I. Compared with other similar medicines in the prior art, the compound or the pharmacologically acceptable salt, the isomer, the prodrug, the polymorphic substance or the solvate thereof provided by the invention have better activity and a more ideal pharmacokinetics characteristic.

Deuterated benzylaminopyrimidine diketone derivative and application thereof

The invention discloses a deuterated benzylaminopyrimidine dione derivative and an application thereof, and a pharmaceutical composition containing the deuterated benzylaminopyrimidine dione derivative, and the deuterated benzylaminopyrimidine dione derivative and the pharmaceutical composition can be used for inhibiting the activity of myosin. The invention also relates to a method for preparingthe compound and the pharmaceutical composition, and an application of the compound and the pharmaceutical composition in treating hypertrophic cardiomyopathy and related heart diseases.

PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS

Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.